NOVENTRA 2ml RETATUTRIDE 32 mg
R2 000,00
Retatrutide 32 mg Injection Pen
Triple-action GLP-1, GIP, and Glucagon receptor agonist therapy for advanced weight management and metabolic support.
Formulated with premium excipients for stability, purity, and consistent results.
SINGLE PATIENT USE ONLY
Contains 1 × Multi-Dose Pre-Filled Pen. Supplied with 10 × sterile, single-use injection needles.
Description
Maximum dose: The packaging states 8 mg once weekly.
Dosing flexibility: The weekly administration day may be adjusted if necessary, provided at least 48 hours between doses.
Missed dose: Administer within 5 days of the scheduled dose.
If more than 5 days have passed, skip the missed dose and continue with the next scheduled dose.
Continuation: Resume regular once-weekly dosing thereafter.
Important safety note: The label contains conflicting information: its dose table lists doses up to 12 mg, while the administration section states a maximum of 8 mg weekly. Retatrutide is investigational and is not an approved weight-loss medicine for routine clinical use. Do not rely on this packaging alone to determine a dose or injection clicks; confirm the product’s authenticity and safety with a qualified healthcare professional before use. – .
Reviews
There are no reviews yet.